Question 1

Which countries lead Inflammatory Bowel Disease research?

Accepted Answer

By volume, the United States and China publish the most (2.2k and 2.2k works in 2022-now).

Question 2

Which institutions lead Inflammatory Bowel Disease research?

Accepted Answer

By volume in 2022-now, Sun Yat-sen University publishes the most Inflammatory Bowel Disease research, followed by Tel Aviv University and Harvard University.

Question 3

Who are the leading researchers in Inflammatory Bowel Disease?

Accepted Answer

The most-cited researchers publishing on Inflammatory Bowel Disease include Douglas G. Altman, Eric S. Lander and Rob Knight.

Question 4

Where is Inflammatory Bowel Disease research done?

Accepted Answer

The largest centres of Inflammatory Bowel Disease research in 2022-now are London (United Kingdom), New York (United States), Guangzhou (China) and Beijing (China).

Question 5

Where is the best place to study Inflammatory Bowel Disease?

Accepted Answer

Among universities, judged by research, University College Cork, Aalborg University and University of Chicago score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Inflammatory Bowel Disease research growing?

Accepted Answer

Output in 2022-2025 was 29% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Inflammatory Bowel Disease.

Question 7

What are the most cited papers in Inflammatory Bowel Disease?

Accepted Answer

The most cited paper in Inflammatory Bowel Disease is "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" (Siew C. Ng, Hai Yun Shi, Nima Hamidi et al., 2017), with 6,147 citations. Next come "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease" (5,631) and "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease" (5,051).